Availability depends on jurisdiction and product classification. Some citicoline products are sold as dietary supplements, while certain formulations may fall under different regulatory categories.\n\nClinically, the key issues are suitability and interaction risk, not merely prescription status—especially if you use neuro/psychiatric medications, or during pregnancy/breastfeeding.\n\nBottom line: it may be OTC in some settings, but that does not replace individualized safety assessment.